病人健康问卷(Patient Health Questionnaire-9,PHQ-9)是一个简便、有效的抑郁障碍自评量表,在抑郁症诊断的辅助和症状严重程度评估方面,均具有良好的信度和效度.在基于评估的治疗策略中,PHQ-9可以作为制订治疗方案的参考,以及治疗过...病人健康问卷(Patient Health Questionnaire-9,PHQ-9)是一个简便、有效的抑郁障碍自评量表,在抑郁症诊断的辅助和症状严重程度评估方面,均具有良好的信度和效度.在基于评估的治疗策略中,PHQ-9可以作为制订治疗方案的参考,以及治疗过程中对疗效的评估工具.PHQ-9的衍生版本PHQ-8,PHQ-2和他评量表PHQ-9-OV,针对不同研究对象,有着相应的临床应用效果.现就PHQ-9在临床的应用及优势进行论述.展开更多
目的评测病人健康问卷-9(patient health questionnaire-9,PHQ-9)在我国脑卒中人群中的信度和效度。方法由经过培训的4名调查员对156例脑卒中患者分别进行Beck抑郁自评量表(Beck depression inventory,BDI)和PHQ-9、汉密尔顿抑郁量表(Ha...目的评测病人健康问卷-9(patient health questionnaire-9,PHQ-9)在我国脑卒中人群中的信度和效度。方法由经过培训的4名调查员对156例脑卒中患者分别进行Beck抑郁自评量表(Beck depression inventory,BDI)和PHQ-9、汉密尔顿抑郁量表(Hamilton depression rating scale,HAMD)和世界卫生组织复合性国际诊断访谈表3.0(World Health Organization composite international diagnostic interview,WHO-CIDI3.0)的评测,分析PHQ-9应用于脑卒中患者的信度、效度。结果克朗巴赫α系数为0.8383,提示该量表内部一致性较好;条目与总分的相关系数为0.533~0.777(P<0.05),各条目间的相关系数为0.183~0.599,提示该量表内部一致性较好;PHQ-9的效标效度为0.599(P<0.01),提示该量表效标效度良好;PHQ-9与BDI的相关系数为0.803(P<0.01),与HAMD的相关系数为0.835(P<0.01),提示该量表结构效度良好。结论 PHQ-9具有良好的信度和效度,基本符合心理测量学标准,是评价卒中后抑郁的可靠、有效工具。展开更多
Purpose: To determine the incidence of depression among pregnant women during the coronavirus disease (COVID-19) pandemic. Methods: A literature search was conducted on July 2022 through PubMed, CINAHL, MEDLINE, CiNii...Purpose: To determine the incidence of depression among pregnant women during the coronavirus disease (COVID-19) pandemic. Methods: A literature search was conducted on July 2022 through PubMed, CINAHL, MEDLINE, CiNii, and the Japan Medical Abstract Society using the keywords “COVID-19”, “Pregnant Women” and “Depression”. The titles/abstracts were screened based on three selection criteria: 1) inclusion of pregnant women;2) description of depression;3) description of COVID-19. Results: Of the 213 articles that were extracted, 104 were excluded owing to duplication and 14 were excluded because they comprised other article types, including reviews and commentaries. Finally, 49 were excluded by title, abstract, and full-text screening. Among the 46 articles that met the inclusion criteria, 13 articles (28.3%) were from China, 8 (17.4%) were from Turkey, 4 (8.7%) were from the United States, and 3 (6.5%) were from Japan. The most common scales used to measure depression were the Edinburgh Postnatal Depression Scale (EPDS) used in 18 articles (39.1%), followed by the Patient Health Questionnaire (PHQ-9) used in 11 articles (23.9%). Furthermore, 46 sources reported a suspected depression rate of 30.0% (20,338/67,860 pregnant women). The rate of depression was 15.1% - 33.5% using EPDS ≥ 9 in three articles and 12.0% - 43.2% using EPDS ≥ 13 in nine articles. The five articles using PHQ-9 ≥ 5 reported 25.8% - 48.7%, and seven articles reported 5.3% - 59.2% using PHQ-9 ≥ 10. Conclusion: Depression was a concern for one out of every three to four pregnant women during the COVID-19 pandemic. This suggests that depression among pregnant women during COVID-19 might have worsened, highlighting the need for mental health support for them.展开更多
The extent of viral spread and strategies in dealing with the COVID-19 pandemic have been different in each country.There are overall increased mental health concerns in many countries but it is unclear what the gener...The extent of viral spread and strategies in dealing with the COVID-19 pandemic have been different in each country.There are overall increased mental health concerns in many countries but it is unclear what the general public individuals who do not have heighten vulnerability to stressors for existing mental diseases or significant physical illnesses were experiencing during the pandemic.We evaluated the stressors and mental health of general public in South Korea that has a relatively low confirmed cases and deaths.Responses on the on-line survey questions were used to assess the mental and physical symptoms in association with individuals’reported stressors.Individuals with the symptoms of the generalized anxiety disorder(GAD)were reported in 58.9%,and major depression(MD)in 23.2%,mostly in minimal to mild degrees,cut-off scores of 5 and 10,respectively by the validated screening tools,GAD-7 and PHQ-9.Both GAD and MD symptoms were in 21.5%of the respondents.The total number of stress had significant association with the scores of GAD-7,PHQ-9,physical symptoms,sleep difficulties and resilience(p<0.01).GAD scores were also associated with sleep difficulties(p<0.01)and raising young children(p<0.05).MD scores were associated with sleep difficulties,job-dissatisfaction,and educational level(p<0.05).The limitations of the study include small sample size,usage of smartphone or email,potential under-reporting by stigma in the socio-cultural context and evolving nature of pandemic.We conclude that keeping careful watch for mental symptoms,stressors,sleep difficulties and other physical symptoms are important even for the individuals without previous mental illnesses during the pandemic era.展开更多
文摘病人健康问卷(Patient Health Questionnaire-9,PHQ-9)是一个简便、有效的抑郁障碍自评量表,在抑郁症诊断的辅助和症状严重程度评估方面,均具有良好的信度和效度.在基于评估的治疗策略中,PHQ-9可以作为制订治疗方案的参考,以及治疗过程中对疗效的评估工具.PHQ-9的衍生版本PHQ-8,PHQ-2和他评量表PHQ-9-OV,针对不同研究对象,有着相应的临床应用效果.现就PHQ-9在临床的应用及优势进行论述.
文摘目的评测病人健康问卷-9(patient health questionnaire-9,PHQ-9)在我国脑卒中人群中的信度和效度。方法由经过培训的4名调查员对156例脑卒中患者分别进行Beck抑郁自评量表(Beck depression inventory,BDI)和PHQ-9、汉密尔顿抑郁量表(Hamilton depression rating scale,HAMD)和世界卫生组织复合性国际诊断访谈表3.0(World Health Organization composite international diagnostic interview,WHO-CIDI3.0)的评测,分析PHQ-9应用于脑卒中患者的信度、效度。结果克朗巴赫α系数为0.8383,提示该量表内部一致性较好;条目与总分的相关系数为0.533~0.777(P<0.05),各条目间的相关系数为0.183~0.599,提示该量表内部一致性较好;PHQ-9的效标效度为0.599(P<0.01),提示该量表效标效度良好;PHQ-9与BDI的相关系数为0.803(P<0.01),与HAMD的相关系数为0.835(P<0.01),提示该量表结构效度良好。结论 PHQ-9具有良好的信度和效度,基本符合心理测量学标准,是评价卒中后抑郁的可靠、有效工具。
文摘Purpose: To determine the incidence of depression among pregnant women during the coronavirus disease (COVID-19) pandemic. Methods: A literature search was conducted on July 2022 through PubMed, CINAHL, MEDLINE, CiNii, and the Japan Medical Abstract Society using the keywords “COVID-19”, “Pregnant Women” and “Depression”. The titles/abstracts were screened based on three selection criteria: 1) inclusion of pregnant women;2) description of depression;3) description of COVID-19. Results: Of the 213 articles that were extracted, 104 were excluded owing to duplication and 14 were excluded because they comprised other article types, including reviews and commentaries. Finally, 49 were excluded by title, abstract, and full-text screening. Among the 46 articles that met the inclusion criteria, 13 articles (28.3%) were from China, 8 (17.4%) were from Turkey, 4 (8.7%) were from the United States, and 3 (6.5%) were from Japan. The most common scales used to measure depression were the Edinburgh Postnatal Depression Scale (EPDS) used in 18 articles (39.1%), followed by the Patient Health Questionnaire (PHQ-9) used in 11 articles (23.9%). Furthermore, 46 sources reported a suspected depression rate of 30.0% (20,338/67,860 pregnant women). The rate of depression was 15.1% - 33.5% using EPDS ≥ 9 in three articles and 12.0% - 43.2% using EPDS ≥ 13 in nine articles. The five articles using PHQ-9 ≥ 5 reported 25.8% - 48.7%, and seven articles reported 5.3% - 59.2% using PHQ-9 ≥ 10. Conclusion: Depression was a concern for one out of every three to four pregnant women during the COVID-19 pandemic. This suggests that depression among pregnant women during COVID-19 might have worsened, highlighting the need for mental health support for them.
文摘The extent of viral spread and strategies in dealing with the COVID-19 pandemic have been different in each country.There are overall increased mental health concerns in many countries but it is unclear what the general public individuals who do not have heighten vulnerability to stressors for existing mental diseases or significant physical illnesses were experiencing during the pandemic.We evaluated the stressors and mental health of general public in South Korea that has a relatively low confirmed cases and deaths.Responses on the on-line survey questions were used to assess the mental and physical symptoms in association with individuals’reported stressors.Individuals with the symptoms of the generalized anxiety disorder(GAD)were reported in 58.9%,and major depression(MD)in 23.2%,mostly in minimal to mild degrees,cut-off scores of 5 and 10,respectively by the validated screening tools,GAD-7 and PHQ-9.Both GAD and MD symptoms were in 21.5%of the respondents.The total number of stress had significant association with the scores of GAD-7,PHQ-9,physical symptoms,sleep difficulties and resilience(p<0.01).GAD scores were also associated with sleep difficulties(p<0.01)and raising young children(p<0.05).MD scores were associated with sleep difficulties,job-dissatisfaction,and educational level(p<0.05).The limitations of the study include small sample size,usage of smartphone or email,potential under-reporting by stigma in the socio-cultural context and evolving nature of pandemic.We conclude that keeping careful watch for mental symptoms,stressors,sleep difficulties and other physical symptoms are important even for the individuals without previous mental illnesses during the pandemic era.